TABLE 3.
Patients’ knowledge of adverse reactions by drugs and patients’ communication in pharmacovigilance.
| Characteristic | Diagnostic response | Interventional response |
|---|---|---|
| n (%) | n (%) | |
| Patients’ knowledge of adverse reactions by drugs | ||
| Patients’ immediate action after suffering from a disease | ||
| a. Immediately consult the doctor for a prescription | 314 (74.2%) | 355 (83.9%) |
| b. Practice self-medication | 109 (25.8%) | 68 (16.1%) |
| Guidance provided by a healthcare professional for safe drug usage | ||
| a. Yes | 271 (64.1%) | 291 (68.8%) |
| b. No | 152 (35.9%) | 132 (31.2%) |
| Patients compliance with healthcare guidance | ||
| a. Completely | 215 (50.8%) | 260 (61.5%) |
| b. Not entirely | 107 (25.3%) | 89 (21%) |
| c. Not followed | 101 (23.9%) | 74 (17.5%) |
| Patients’ understanding about adverse reactions by drugs | ||
| a. Harmful response by a drug* | 149 (35.2%) | 318 (75.2%) |
| b. Routine side effect | 67 (15.8%) | 57 (13.5%) |
| c. Desired response | 59 (13.9%) | 48 (11.3%) |
| d. Do not know | 148 (35%) | 0 |
| Patients’ perception regarding the purpose of reporting adverse reactions by drugs | ||
| a. Drug safety improve by reporting | 80 (18.9%) | 270 (63.8%) |
| b. Reoccurrence will be prevented | 150 (35.5%) | 107 (25.3%) |
| c. Prerequisite in the hospital setting | 62 (14.7%) | 42 (9.9%) |
| d. Enable physicians for early diagnosis | 131 (31%) | 4 (0.9%) |
| Vulnerable population for developing adverse reactions by drugs | ||
| a. Child populace | 139 (32.9%) | 112 (26.5%) |
| b. Adult population | 49 (11.6%) | 31 (7.3%) |
| c. Old age people | 82 (19.4%) | 53 (12.5%) |
| d. All of the above | 153 (36.2%) | 227 (53.7%) |
| Appropriate person in the healthcare team for reporting adverse reactions by drugs | ||
| a. Physician | 84 (19.9%) | 145 (34.2%) |
| b. Pharmacist | 42 (9.9%) | 58 (13.7%) |
| c. Nurse | 42 (9.9%) | 57 (13.5%) |
| d. All of the above | 107 (25.3%) | 163 (38.6%) |
| e. Do not know | 148 (35.0%) | 0 |
| Do you have the knowledge of pharmacovigilance as the science of detecting adverse drug reactions? | ||
| a. Yes | 121 (28.6%) | 414 (97.9%) |
| b. No | 302 (71.4%) | 9 (2.1%) |
| Knowledge of online forms for reporting drug reactions | ||
| a. Yes | 242 (57.2%) | 420 (99.3%) |
| b. No | 181 (42.8%) | 3 (0.7%) |
| Patients’ communication in pharmacovigilance | ||
| Discussion with the physician about the probability of adverse drug reactions before taking medication | ||
| a. Yes | 204 (48.2%) | 317 (74.9%) |
| b. No | 219 (51.8%) | 106 (25.1) |
| Discussion with the physician about dose frequency and timing of medicines | ||
| a. Yes | 252 (59.6%) | 403 (95.3%) |
| b. No | 171 (40.4%) | 20 (4.7%) |
| Discussion with the physician about precautions and instructions related to prescription | ||
| a. Yes | 267 (63.1%) | 359 (84.9%) |
| b. No | 156 (36.9%) | 64 (15.1%) |
| Show compliance with prescriber instructions | ||
| a. Yes | 315 (74.5%) | 359 (84.9%) |
| b. No | 108 (25.5%) | 64 (15.1%) |
| Did/will you review the drug brochure about the adverse reaction of the drugs before taking the medication? | ||
| a. Yes | 219 (51.8%) | 370 (87.5%) |
| b. No | 204 (48.2.%) | 53 (12.5%) |
*Correct response.